NEW YORK, Oct. 21 (GenomeWeb News) - Tata Consultancy Services of Mombai, India, and Israeli pharma BioStrx will co-develop lead drug compounds, the companies said last week.

 

The companies will collaborate on protein crystallization and structure determination to provide optimized lead compounds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.